[go: up one dir, main page]

IL129397A0 - Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof - Google Patents

Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof

Info

Publication number
IL129397A0
IL129397A0 IL12939797A IL12939797A IL129397A0 IL 129397 A0 IL129397 A0 IL 129397A0 IL 12939797 A IL12939797 A IL 12939797A IL 12939797 A IL12939797 A IL 12939797A IL 129397 A0 IL129397 A0 IL 129397A0
Authority
IL
Israel
Prior art keywords
helicobacter pylori
vaccine compositions
amino acid
nucleic acid
acid sequences
Prior art date
Application number
IL12939797A
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of IL129397A0 publication Critical patent/IL129397A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL12939797A 1996-10-28 1997-10-28 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof IL129397A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US73915096A 1996-10-28 1996-10-28
US75973996A 1996-12-06 1996-12-06
US89192897A 1997-07-14 1997-07-14
PCT/US1997/019575 WO1998018323A1 (en) 1996-10-28 1997-10-28 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof

Publications (1)

Publication Number Publication Date
IL129397A0 true IL129397A0 (en) 2000-02-17

Family

ID=27419246

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12939797A IL129397A0 (en) 1996-10-28 1997-10-28 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof

Country Status (19)

Country Link
EP (1) EP0973394A4 (en)
JP (1) JP2001504329A (en)
KR (1) KR20000052831A (en)
CN (1) CN1235513A (en)
AR (1) AR009600A1 (en)
AU (1) AU734052B2 (en)
BR (1) BR9712587A (en)
CA (1) CA2265523A1 (en)
EE (1) EE9900176A (en)
ID (1) ID22065A (en)
IL (1) IL129397A0 (en)
IS (1) IS5005A (en)
NO (1) NO991995L (en)
NZ (1) NZ334568A (en)
PL (1) PL333169A1 (en)
SA (1) SA98180918A (en)
SK (1) SK34699A3 (en)
TR (1) TR199900940T2 (en)
WO (1) WO1998018323A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406703B1 (en) 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
CA2154063C (en) * 1993-07-27 2006-11-21 Christopher Vincent Doidge Treatment of h. pylori associated gastroduodenal disease
DE19730425A1 (en) 1997-07-16 1999-01-21 Henkel Teroson Gmbh Heat-curing laundry-resistant shell sealant
AU4793499A (en) * 1998-07-27 2000-02-21 Aventis Pasteur Limited (chlamydia) antigens and corresponding dna fragments and uses thereof
SE9901548D0 (en) * 1999-04-29 1999-04-29 Astra Ab Helicobacter pylori antigens
GB9914945D0 (en) * 1999-06-25 1999-08-25 Smithkline Beecham Biolog Novel compounds
AUPQ347199A0 (en) * 1999-10-15 1999-11-11 Csl Limited Novel polypeptide fragments
JP5571274B2 (en) 2000-03-08 2014-08-13 ノボザイムス アクティーゼルスカブ Variants with altered properties
GB0010370D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
GB0010371D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
EP2695938B1 (en) 2011-03-17 2016-11-30 National UniversityCorporation Mie University Antibody production method
CA3007036A1 (en) * 2015-12-14 2017-06-22 Technische Universitat Munchen Helicobacter pylori vaccines
CN115724922B (en) * 2022-07-19 2023-08-22 四川大学华西医院 A kind of Helicobacter pylori vaccine recombinant protein antigen TonB and its preparation method and application
CN115581201A (en) * 2022-08-26 2023-01-10 云南省农业科学院花卉研究所 Diploid rose F induced by stem segment as explant 1 -61 plant regeneration method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9300139L (en) * 1993-01-19 1994-07-20 Medicarb Ab Preparation of a new drug

Also Published As

Publication number Publication date
AR009600A1 (en) 2000-04-26
SA98180918A (en) 2005-12-03
EP0973394A1 (en) 2000-01-26
AU5093398A (en) 1998-05-22
EE9900176A (en) 1999-12-15
BR9712587A (en) 1999-10-26
AU734052B2 (en) 2001-05-31
TR199900940T2 (en) 1999-09-21
EP0973394A4 (en) 2005-03-30
CN1235513A (en) 1999-11-17
KR20000052831A (en) 2000-08-25
CA2265523A1 (en) 1998-05-07
NO991995D0 (en) 1999-04-27
ID22065A (en) 1999-08-26
IS5005A (en) 1999-03-18
PL333169A1 (en) 1999-11-22
NZ334568A (en) 2000-04-28
JP2001504329A (en) 2001-04-03
SK34699A3 (en) 2000-04-10
WO1998018323A1 (en) 1998-05-07
NO991995L (en) 1999-06-28

Similar Documents

Publication Publication Date Title
SK165197A3 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
HUP0100267A3 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
HUP9901546A3 (en) Helicobacter pylori antigens and vaccine compositions
IL129397A0 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
IL129746A0 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
AU1698699A (en) (helicobacter pylori) vaccine formulations
AU1055497A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
ZA979672B (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine composition thereof
HUP9903843A3 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
HUP0000521A3 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
ZA9710971B (en) Nucleic acid and amino acid sequences relating to Helicobacter pylori and vaccine compositions thereof.
ZA972715B (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof.
HK1024176A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
HK1024597A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
HK1017385A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
IL133144A0 (en) Vaccine compositions comprising the helicobacter pylori flge polypeptide
HUP9900766A3 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
ZA964869B (en) Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
GB9413073D0 (en) Helicobacter pylori vaccines/therapeutic compositions
HK1005808A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
RU99111594A (en) HELICOBACTER PYLORI NUCLEIC ACID AND AMINO ACID SEQUENCES AND THEIR VACCINE COMPOSITIONS
RU99114027A (en) HELICOBACTER PYLORY NUCLEIC ACID AND AMINO ACID SEQUENCES AND THEIR VACCINE COMPOSITIONS
AU7537598A (en) Dna based anti-(helicobacter) vaccine composition
GB9610192D0 (en) DNA vaccine formulations
IL140354A0 (en) 128 novel nucleic acid and amino acid sequences